Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 184

    1.

    [Overview of measles, mumps, rubella and varicella vaccination in adolescents and adults]

    Quast U, Arndt U.

    Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S77-81. Epub 2009 Apr 7. Review. German. PMID: 19353476 [PubMed - indexed for MEDLINE]Related articles

    2.

    Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibition.

    Russ U, Kühner P, Prager R, Stephan D, Bryan J, Quast U.

    Br J Pharmacol. 2009 Jan;156(2):354-61. Epub 2009 Jan 13.PMID: 19154434 [PubMed - indexed for MEDLINE]Related articles

    3.

    Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.

    Winkler M, Lutz R, Russ U, Quast U, Bryan J.

    J Biol Chem. 2009 Mar 13;284(11):6752-62. Epub 2009 Jan 12.PMID: 19139106 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of adenosine on membrane potential and Ca2+ in juxtaglomerular cells. Comparison with angiotensin II.

    Laske-Ernst J, Stehle A, Vallon V, Quast U, Russ U.

    Kidney Blood Press Res. 2008;31(2):94-103. Epub 2008 Mar 6.PMID: 18322364 [PubMed - indexed for MEDLINE]Related articles

    5.

    Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.

    Winkler M, Stephan D, Bieger S, Kühner P, Wolff F, Quast U.

    J Pharmacol Exp Ther. 2007 Aug;322(2):701-8. Epub 2007 May 10.PMID: 17495126 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    KATP channel openers of the benzopyran type reach their binding site via the cytosol.

    Stephan D, Salamon E, Weber H, Russ U, Lemoine H, Quast U.

    Br J Pharmacol. 2006 Sep;149(2):199-205. Epub 2006 Aug 14.PMID: 16921394 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.

    Stephan D, Winkler M, Kühner P, Russ U, Quast U.

    Diabetologia. 2006 Sep;49(9):2039-48. Epub 2006 Jul 25.PMID: 16865362 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lipids modulate ligand binding to sulphonylurea receptors.

    Klein A, Lichtenberg J, Stephan D, Quast U.

    Br J Pharmacol. 2005 Aug;145(7):907-15.PMID: 15895108 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

    Stephan D, Stauss E, Lange U, Felsch H, Löffler-Walz C, Hambrock A, Russ U, Quast U.

    Br J Pharmacol. 2005 Apr;144(8):1078-88.PMID: 15711591 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium.

    Quast U, Stephan D, Bieger S, Russ U.

    Diabetes. 2004 Dec;53 Suppl 3:S156-64. Review.PMID: 15561904 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Electrophysiological and molecular characterization of the inward rectifier in juxtaglomerular cells from rat kidney.

    Leichtle A, Rauch U, Albinus M, Benöhr P, Kalbacher H, Mack AF, Veh RW, Quast U, Russ U.

    J Physiol. 2004 Oct 15;560(Pt 2):365-76. Epub 2004 Jul 29.PMID: 15284349 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.

    Felsch H, Lange U, Hambrock A, Löffler-Walz C, Russ U, Carroll WA, Gopalakrishnan M, Quast U.

    Br J Pharmacol. 2004 Apr;141(7):1098-105. Epub 2004 Mar 15.PMID: 15023854 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Virtual 3D IVUS vessel model for intravascular brachytherapy planning. I. 3D segmentation, reconstruction, and visualization of coronary artery architecture and orientation.

    Weichert F, Müller H, Quast U, Kraushaar A, Spilles P, Heintz M, Wilke C, von Birgelen C, Erbel R, Wegener D.

    Med Phys. 2003 Sep;30(9):2530-6.PMID: 14528975 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical beta radiation dosimetry for brachytherapy in terms of absorbed dose to water: ISO new work item proposal for international standardization.

    Quast U, Böhm J, Kaulich TW.

    Cardiovasc Radiat Med. 2002 Jul-Dec;3(3-4):209-12. Review.PMID: 12974376 [PubMed - indexed for MEDLINE]Related articles

    15.

    Binding and effect of K ATP channel openers in the absence of Mg2+.

    Russ U, Lange U, Löffler-Walz C, Hambrock A, Quast U.

    Br J Pharmacol. 2003 May;139(2):368-80.PMID: 12770942 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Dose finding in intracoronary brachytherapy--consequences from empirical trials.

    Baumgart D, Sauerwein W, Naber C, Meusers P, Quast U, Eggebrecht H, Erbel R.

    Z Kardiol. 2002;91 Suppl 3:23-30. Review.PMID: 12641012 [PubMed - indexed for MEDLINE]Related articles

    17.

    Mg2+ sensitizes KATP channels to inhibition by DIDS: dependence on the sulphonylurea receptor subunit.

    Gojkovic-Bukarica L, Hambrock A, Löffler-Walz C, Quast U, Russ U.

    Br J Pharmacol. 2002 Oct;137(4):429-40.PMID: 12359624 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The stereoenantiomers of a pinacidil analog open or close cloned ATP-sensitive K+ channels.

    Lange U, Löffler-Walz C, Englert HC, Hambrock A, Russ U, Quast U.

    J Biol Chem. 2002 Oct 25;277(43):40196-205. Epub 2002 Aug 8.PMID: 12171936 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The influence of guiding equipment and stents on the beta dose distribution in the brachytherapy of in-stent restenosis.

    Flühs D, Wilke C, Naber C, Hienz M, Bambynek M, Kaiser C, Langner I, Baumgart D, Sauerwein W, Wegener D, Quast U.

    Cardiovasc Radiat Med. 2001 Oct-Dec;2(4):241-5.PMID: 12160766 [PubMed - indexed for MEDLINE]Related articles

    20.

    DGMP guideline for medical physical aspects of intravascular brachytherapy. Part II: Samples and examples.

    Quast U, Kaulich TW, Flühs D; DGMP Working Group.

    Z Med Phys. 2002;12(2):133-48. No abstract available. PMID: 12145910 [PubMed - indexed for MEDLINE]Related articles

    21.

    Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.

    Hambrock A, Löffler-Walz C, Quast U.

    Br J Pharmacol. 2002 Aug;136(7):995-1004.PMID: 12145099 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Four novel splice variants of sulfonylurea receptor 1.

    Hambrock A, Preisig-Müller R, Russ U, Piehl A, Hanley PJ, Ray J, Daut J, Quast U, Derst C.

    Am J Physiol Cell Physiol. 2002 Aug;283(2):C587-98.PMID: 12107069 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    DGMP guideline for medical physical aspects of intravascular brachytherapy. Part I: Guideline.

    Quast U, Kaulich TW, Flühs D; German Society for Medical Physics c.V.

    Z Med Phys. 2002;12(1):47-64. No abstract available. PMID: 12001372 [PubMed - indexed for MEDLINE]Related articles

    25.

    KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects.

    Buchheit KH, Manley PW, Quast U, Russ U, Mazzoni L, Fozard JR.

    Naunyn Schmiedebergs Arch Pharmacol. 2002 Mar;365(3):220-30. Epub 2002 Jan 23.PMID: 11882918 [PubMed - indexed for MEDLINE]Related articles

    26.

    Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.

    Löffler-Walz C, Hambrock A, Quast U.

    Mol Pharmacol. 2002 Feb;61(2):407-14.PMID: 11809866 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.

    Russ U, Lange U, Löffler-Walz C, Hambrock A, Quast U.

    J Pharmacol Exp Ther. 2001 Dec;299(3):1049-55.PMID: 11714894 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    [Suspected diphtheria. Immediately start therapy!]

    Stück B, Quast U, Ley S.

    MMW Fortschr Med. 2001 Oct 4;143(40):28-32. German. PMID: 11692840 [PubMed - indexed for MEDLINE]Related articles

    29.

    Chromanol 293B, a blocker of the slow delayed rectifier K+ current (IKs), inhibits the CFTR Cl- current.

    Bachmann A, Quast U, Russ U.

    Naunyn Schmiedebergs Arch Pharmacol. 2001 Jun;363(6):590-6.PMID: 11414653 [PubMed - indexed for MEDLINE]Related articles

    30.

    Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.

    Hambrock A, Löffler-Walz C, Russ U, Lange U, Quast U.

    Mol Pharmacol. 2001 Jul;60(1):190-9.PMID: 11408614 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    [Repaglinide]

    Quast U.

    Dtsch Med Wochenschr. 2001 May 11;126(19):559-60. German. No abstract available. PMID: 11402913 [PubMed - indexed for MEDLINE]Related articles

    32.

    Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.

    Manley PW, Löffler-Walz C, Russ U, Hambrock A, Moenius T, Quast U.

    Br J Pharmacol. 2001 May;133(2):275-85.PMID: 11350864 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    [Vaccination record. Patient data series]

    Quast U, Maass G.

    MMW Fortschr Med. 2000 Dec 7;142(49-50):50-2. German. No abstract available. PMID: 11190941 [PubMed - indexed for MEDLINE]Related articles

    34.

    Potent stimulation and inhibition of the CFTR Cl(-) current by phloxine B.

    Bachmann A, Russ U, Waldegger S, Quast U.

    Br J Pharmacol. 2000 Oct;131(3):433-40.PMID: 11015292 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    [Structure of ATP-dependent potassium channels: SUR/Kir6 molecular complex]

    Quast U.

    Journ Annu Diabetol Hotel Dieu. 2000:1-12. Review. French. No abstract available. PMID: 10932864 [PubMed - indexed for MEDLINE]Related articles

    36.

    In-phantom response of LiF TLD-100 for dosimetry of 192Ir HDR source.

    Pradhan AS, Quast U.

    Med Phys. 2000 May;27(5):1025-9.PMID: 10841406 [PubMed - indexed for MEDLINE]Related articles

    37.

    Reporting vascular brachytherapy: proposal for a revision of the AAPM TG 60 report. American Association of Physicists in Medicine.

    Quast U.

    Cardiovasc Radiat Med. 1999 Oct-Dec;1(4):378-81. No abstract available. PMID: 10828569 [PubMed - indexed for MEDLINE]Related articles

    38.

    A high-precision, high-resolution and fast dosimetry system for beta sources applied in cardiovascular brachytherapy.

    Bambynek M, Flühs D, Quast U, Wegener D, Soares CG.

    Med Phys. 2000 Apr;27(4):662-7.PMID: 10798687 [PubMed - indexed for MEDLINE]Related articles

    39.

    Atypical effect of minoxidil sulphate on guinea pig airways.

    Buchheit KH, Hofmann A, Manley P, Pfannkuche HJ, Quast U.

    Naunyn Schmiedebergs Arch Pharmacol. 2000 Apr;361(4):418-24.PMID: 10763857 [PubMed - indexed for MEDLINE]Related articles

    40.

    Vasorelaxation by new hybrid compounds containing dihydropyridine and pinacidil-like moieties.

    Yagupolskii LM, Antepohl W, Artunc F, Handrock R, Klebanov BM, Maletina II, Marxen B, Petko KI, Quast U, Vogt A, Weiss C, Zibold J, Herzig S.

    J Med Chem. 1999 Dec 16;42(25):5266-71.PMID: 10602711 [PubMed - indexed for MEDLINE]Related articles

    41.

    Fluorescence 125I eye applicator.

    Bambynek M, Flühs D, Heintz M, Kolanoski H, Wegener D, Quast U.

    Med Phys. 1999 Nov;26(11):2476-81.PMID: 10587236 [PubMed - indexed for MEDLINE]Related articles

    42.

    Potent inhibition of the CFTR chloride channel by suramin.

    Bachmann A, Russ U, Quast U.

    Naunyn Schmiedebergs Arch Pharmacol. 1999 Oct;360(4):473-6.PMID: 10551285 [PubMed - indexed for MEDLINE]Related articles

    43.

    Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.

    Russ U, Hambrock A, Artunc F, Löffler-Walz C, Horio Y, Kurachi Y, Quast U.

    Mol Pharmacol. 1999 Nov;56(5):955-61.PMID: 10531400 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney.

    Russ U, Rauch U, Quast U.

    J Physiol. 1999 Jun 15;517 ( Pt 3):781-90.PMID: 10358118 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.

    Hambrock A, Löffler-Walz C, Kloor D, Delabar U, Horio Y, Kurachi Y, Quast U.

    Mol Pharmacol. 1999 May;55(5):832-40.PMID: 10220561 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Effects of ions on adenosine binding and enzyme activity of purified S-adenosylhomocysteine hydrolase from bovine kidney.

    Kloor D, Fuchs S, Petroktistis F, Delabar U, Mühlbauer B, Quast U, Osswald H.

    Biochem Pharmacol. 1998 Dec 1;56(11):1493-6.PMID: 9827583 [PubMed - indexed for MEDLINE]Related articles

    47.

    Endovascular brachytherapy--treatment planning and radiation protection.

    Quast U, Flühs D, Bambynek M.

    Herz. 1998 Sep;23(6):337-46. Review.PMID: 9816519 [PubMed - indexed for MEDLINE]Related articles

    48.

    Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.

    Hambrock A, Löffler-Walz C, Kurachi Y, Quast U.

    Br J Pharmacol. 1998 Oct;125(3):577-83.PMID: 9806343 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.

    Löffler-Walz C, Quast U.

    Naunyn Schmiedebergs Arch Pharmacol. 1998 Aug;358(2):230-7.PMID: 9750009 [PubMed - indexed for MEDLINE]Related articles

    50.

    Binding of K(ATP) channel modulators in rat cardiac membranes.

    Löffler-Walz C, Quast U.

    Br J Pharmacol. 1998 Apr;123(7):1395-402.PMID: 9579735 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...